反应详情

The title compound was prepared following the procedure of example one with N5-(2-chloro-pyrimidin-4-yl)-N2-(4-fluoro-benzyl)-1,N5-dimethyl-1H-benzoimidazole-2,5-diamine (99 mg, 0.25 mmol) and 3-amino-benzenesulfonamide (43 mg, 0.25 mmol) as a white solid (104 mg, 73%). 1H NMR (300 MHz, d6-DMSO+NaHCO3) δ 10.08 (br s, 1H), 9.57 (br s, 1H), 8.46 (s, 1H), 7.87 (d, J=1.8 Hz, 1H), 7.73 (m, 1H), 7.55-7.58 (m, 3H), 7.40 (d, J=3.3 Hz, 2H), 7.35 (s, 1H), 7.30 (s, 2H), 7.16-7.23 (m, 3H), 5.74 (d, J=4.5 Hz, 1H), 4.73 (d, J=4.2 Hz, 2H), 3.71 (s, 3H), 3.47 (s, 3H). MS (ESI) m/z=533 [M+H]+.